Regulation - CSL Limited


Current filters:

CSL Limited

Popular Filters

Benefits of Kogenate/Helixate NexGen outweigh risks, says EMA unit

Benefits of Kogenate/Helixate NexGen outweigh risks, says EMA unit


The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) has reviewed the…

BayerCardio-vascularCSL BehringCSL LimitedEuropeHelixateHematologyKogenatePharmaceuticalRegulation

CSL Behring's Berinert OKed in Europe for short-term prophylaxis in HAE


Germany-based CSL Behring, a unit of Australia's CSL Ltd (ASX: CSL) says that European health authorities…

BerinertBiotechnologyCSL BehringCSL LimitedEuropeRare diseasesRegulation

CSL Behring gains expanded use for Corifact in USA


Corifact, Factor XIII Concentrate (Human), to include the peri-operative management of surgical bleeding…

CorifactCSL BehringCSL LimitedNorth AmericaPharmaceuticalRare diseasesRegulation

PharmaJet links with Australia's CSL for needle-free flu vaccine delivery


USA-based PharmaJet has entered into a collaboration with Australia's largest biotech firm CSL Limited…

AfluriaAnti-viralsCSL LimitedHomeNorth AmericaPharmaJetProductionRegulation

Back to top